Slideshow

Key Concepts About Polypharmacy in Psychotic Disorders

Author(s):

Jose M. Rubio, MD

Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
nicotine use
brain schizophrenia
schizophrenia
schizophrenia
exciting, brain
Related Content
renal
December 20th 2024

Demystifying Lithium Therapy—A Primer for Clinicians: Renal Issues, Part 1

Jonathan M. Meyer, MD, DLFAPA
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
criminal psychosis
December 18th 2024

Criminal Sanctions, Psychosis, and Mortality

Megan McSweeney
Treating ‘Morally Objectionable’ Patients
September 27th 2021

Treating ‘Morally Objectionable’ Patients

James L. Knoll IV, MD
schizophrenia
December 11th 2024

Combating Negative Symptoms in Schizophrenia: Updated Treatment Approaches

Michel Sabé, MD
Innovative Biomarker Research Focuses More at Controls
December 11th 2024

Innovative Biomarker Research Focuses More at Controls

Heidi Anne Duerr, MPH Arthur Caye, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.